JP2002508959A5 - - Google Patents

Download PDF

Info

Publication number
JP2002508959A5
JP2002508959A5 JP2000540221A JP2000540221A JP2002508959A5 JP 2002508959 A5 JP2002508959 A5 JP 2002508959A5 JP 2000540221 A JP2000540221 A JP 2000540221A JP 2000540221 A JP2000540221 A JP 2000540221A JP 2002508959 A5 JP2002508959 A5 JP 2002508959A5
Authority
JP
Japan
Prior art keywords
anticodon
sequence
trna
cell
introducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000540221A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002508959A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/000717 external-priority patent/WO1999036519A1/en
Publication of JP2002508959A publication Critical patent/JP2002508959A/ja
Publication of JP2002508959A5 publication Critical patent/JP2002508959A5/ja
Pending legal-status Critical Current

Links

JP2000540221A 1998-01-14 1999-01-13 ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法 Pending JP2002508959A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7141698P 1998-01-14 1998-01-14
US60/071,416 1998-01-14
PCT/US1999/000717 WO1999036519A1 (en) 1998-01-14 1999-01-13 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME

Publications (2)

Publication Number Publication Date
JP2002508959A JP2002508959A (ja) 2002-03-26
JP2002508959A5 true JP2002508959A5 (cg-RX-API-DMAC7.html) 2006-02-23

Family

ID=22101183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000540221A Pending JP2002508959A (ja) 1998-01-14 1999-01-13 ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法

Country Status (8)

Country Link
US (2) US6309830B1 (cg-RX-API-DMAC7.html)
EP (1) EP1045902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002508959A (cg-RX-API-DMAC7.html)
AT (1) ATE299179T1 (cg-RX-API-DMAC7.html)
AU (1) AU2225199A (cg-RX-API-DMAC7.html)
CA (1) CA2318374C (cg-RX-API-DMAC7.html)
DE (1) DE69926052T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999036519A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法
KR20010079671A (ko) * 1998-08-20 2001-08-22 스티븐 에이. 서윈. 엠.디. 재조합 유전자 생성물을 생성시키는 동안 세포독성을조절하는 억제 tRNA의 용도
WO2003033521A1 (en) * 2001-10-16 2003-04-24 Massachusetts Institute Of Technology Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides.
US20050261210A1 (en) * 2004-02-19 2005-11-24 Bhatnagar Rajiv S Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
WO2005086768A2 (en) * 2004-03-11 2005-09-22 Albert Einstein College Of Medicine Of Yeshiva University Enhanced production of functional proteins from defective genes
WO2008064304A2 (en) * 2006-11-22 2008-05-29 Trana Discovery, Inc. Compositions and methods for the identification of inhibitors of protein synthesis
ATE553764T1 (de) * 2007-09-14 2012-05-15 Trana Discovery Zusammensetzungen und verfahren zur identifizierung von inhibitoren einer retrovirusinfektion
CA2776044A1 (en) * 2008-09-29 2010-04-01 Trana Discovery, Inc. Screening methods for identifying specific staphylococcus aureus inhibitors
CN107177592B (zh) * 2016-03-10 2021-03-30 北京大学 抑制性tRNA通读提前终止密码子疾病中的截短蛋白
CN110612353A (zh) * 2017-03-03 2019-12-24 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
MX2020004587A (es) * 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022528696A (ja) * 2019-04-11 2022-06-15 アークタラス テラピュウティクス、インク アンチコドンループを延長した合成転移rna
LU101182B1 (en) * 2019-04-11 2020-10-12 Univ Hamburg Synthetic transfer RNA with extended anticodon loop
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
US11827880B2 (en) 2019-12-02 2023-11-28 Shape Therapeutics Inc. Therapeutic editing
BR112022020780A2 (pt) 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
WO2022125531A1 (en) * 2020-12-07 2022-06-16 President And Fellows Of Harvard College Methods for making and using genomically recoded cells
AU2023212951A1 (en) * 2022-01-25 2024-08-29 Hc Bioscience, Inc. Universal suppressor trnas and uses thereof
USD1118947S1 (en) * 2024-05-29 2026-03-17 Shock Doctor, Inc. Knee brace
USD1121161S1 (en) * 2024-05-29 2026-03-31 Shock Doctor, Inc. Knee brace

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687737A (en) 1982-11-12 1987-08-18 Massachusetts Institute Of Technology Mammalian suppressor genes
US4970155A (en) * 1983-03-07 1990-11-13 Abbott Laboratories HSV helper virus independent vector
US6111095A (en) * 1995-06-07 2000-08-29 Merck & Co., Inc. Capped synthetic RNA, analogs, and aptamers
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法

Similar Documents

Publication Publication Date Title
US20220333102A1 (en) Novel crispr dna targeting enzymes and systems
JP6500293B2 (ja) Dnaメチル化編集用キットおよびdnaメチル化編集方法
RU2709655C2 (ru) Транспозиция с сохранением сцепления генов
Blitz et al. Biallelic genome modification in F0 Xenopus tropicalis embryos using the CRISPR/Cas system
CN114634930B (zh) 使用rna指导型内切核酸酶改善基因组工程特异性的组合物和方法
JP2025161809A (ja) 新規crispr dnaターゲティング酵素及びシステム
WO2002092764A3 (en) Transgenic animal model of bone mass modulation
Kanno et al. A SNF2-like protein facilitates dynamic control of DNA methylation
MXPA03010077A (es) Abonadora de siembra a voleo con deflector movible.
US20220049273A1 (en) Novel crispr dna targeting enzymes and systems
Singh et al. CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
CN114269912A (zh) 新型crispr dna靶向酶及系统
CA3153005A1 (en) Novel crispr dna targeting enzymes and systems
CA2318374A1 (en) Human suppressor trna oligonucleotides and methods of use for same
WO2004067709A3 (en) Identification of essential genes of aspergillus fumigatus and methods of use
WO2001075112A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001074863A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075111A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075114A3 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2002033046A3 (en) Glucose transport-related genes and uses thereof
WO1999054436A3 (en) Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.